| |
Many of today’s clinical trials demand centralized processing of ECG data for cardiac safety assessment. That is why Clinilabs recently introduced ECG processing at its core data center, offering three-dimensional technology to enhance ECG reads.
Clinilabs has partnered with NewCardio to provide core ECG laboratory services with QTinno™, an automated system that offers a level of productivity, precision, and accuracy in centralized ECG data processing that has never before been available to industry. QTinno™ technology synthesizes the data obtained from a standard 12-lead ECG into a single vector lead, providing a robust signal for the assessment of cardiac activity in routine studies, as well as thorough QT and cardiac intensive trials. The performance of QTinno™ has been validated using thousands of ECGs, confirming agreement with the gold standard generated by careful manual or semi-automated reading by highly-qualified cardiologists.
Automated core ECG services significantly reduce the cost and variability of processing ECG data from clinical trials when compared with manual or semi-automated methods. Our clients receive results at a highly competitive cost, faster than ever before.
|
